Publications

Rethinking village malaria workers in Cambodia: Perspectives from the communities, programme managers, and international stakeholders.

Orng, LH; Jongdeepaisal, M; Khonputsa, P; Dysoley, L; Sovannaroth, S; Peto, TJ; Callery, JJ; Pell, C; Maude, RJ; LIVERANI, M;

2024

PLOS global public health, (2024).4 12 10.1371/journal.pgph.0003962.

IMC1g knockdowns reveal malaria blood-stage alveolin functions.

TREMP, AZ; Saeed, S; DESSENS, JT;

2024

Trends in parasitology, (2024).41 1 10.1016/j.pt.2024.11.012.

Plasmodium knowlesi Infection Is Associated With Elevated Circulating Biomarkers of Brain Injury and Endothelial Activation.

Bertran-Cobo, C; Dumont, E; Noordin, NR; Lai, M-Y; STONE, W; Tetteh, KK A; DRAKELEY, C; Krishna, S; Lau, Y-L; WASSMER, SC;

2024

The Journal of Infectious Diseases, (2024).231 5 10.1093/infdis/jiae553.

Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children.

Natama, HM; Salkeld, J; Somé, A; SOREMEKUN, S; Diallo, S; Traoré, O; Rouamba, T; Ouédraogo, F; Ouédraogo, E; Daboné, KC S; Koné, NA; Compaoré, ZM J; Kafando, M; Bonko, MD A; Konaté, F; Sorgho, H; Nielsen, CM; Pipini, D; Diouf, A; King, LD W; Shaligram, U; Long, CA; Cho, J-S; Lawrie, AM; Skinner, K; ... Minassian, AM.

2024

The Lancet. Infectious diseases, (2024).25 5 10.1016/S1473-3099(24)00752-7.

A potent and selective reaction hijacking inhibitor of Plasmodium falciparum tyrosine tRNA synthetase exhibits single dose oral efficacy in vivo.

Xie, SC; Tai, C-W; Morton, CJ; Ma, L; Huang, S-C; Wittlin, S; Du, Y; Hu, Y; Dogovski, C; Salimimarand, M; Griffin, R; England, D; De la Cruz, E; Deni, I; Yeo, T; Burkhard, AY; Striepen, J; Schindler, KA; Crespo, B; Gamo, FJ; Khandokar, Y; Hutton, CA; Rabie, T; Birkholtz, L-M; Famodimu, MT; ... Tilley, L.

2024

PLoS pathogens, (2024).20 12 10.1371/journal.ppat.1012429.

Post-treatment duration of positivity for standard and ultra-sensitive Plasmodium falciparum antigen-based rapid diagnostic tests, a cohort study from a low-endemic setting in Namibia.

Ntuku, H; Whittemore, B; Dausab, L; Jang, IK; Golden, A; Sheahan, W; Wu, X; Slater, H; Domingo, GJ; Das, S; Duarte, E; Eloff, L; Bousema, T; Lanke, K; Gueye, CS; Prach, LM; Raman, J; Uusiku, P; Katokele, S; GOSLING, R; Greenhouse, B; Mumbengegwi, D; Hsiang, MS;

2024

EBioMedicine, (2024).111, 10.1016/j.ebiom.2024.105489.

Freedom from infection: enhancing decision-making for malaria elimination.

Nelli, L; Surendra, H; BYRNE, I; Ahmad, RA; Arisanti, RR; Lesmanawati, DA S; Elyazar, IR F; Dumont, E; Wu, L; DRAKELEY, C; Matthiopoulos, J; Stresman, G;

2024

BMJ global health, (2024).9 12 10.1136/bmjgh-2023-014412.

The spread of molecular markers of artemisinin partial resistance and diagnostic evasion in Eritrea: a retrospective molecular epidemiology study.

Mihreteab, S; Anderson, K; Fuente, IM D L; SUTHERLAND, CJ; Smith, D; Cunningham, J; BESHIR, KB; Cheng, Q;

2024

The Lancet. Microbe, (2024).6 2 10.1016/S2666-5247(24)00172-1.

Inhibitors of malaria parasite cyclic nucleotide phosphodiesterases block asexual blood-stage development and mosquito transmission.

Gomez-Gonzalez, P-J; Gupta, A; Drought, LG; Patel, A; Okombo, J; Van der Watt, M; WALKER-GRAY, R; Schindler, KA; Burkhard, AY; Yeo, T; Narwal, SK; Bloxham, TS; Flueck, C; Walker, EM; Rey, JA; Fairhurst, KJ; Reader, J; Park, H; Pollard, HG; STEWART, LB; BRANDNER-GARROD, L; KRISTAN, M; Sterk, G-J; Van Nuland, YM; Manko, E; ... BAKER, DA.

2024

Science advances, (2024).10 49 10.1126/sciadv.adq1383.

Forest-Going as a Risk Factor for Confirmed Malaria in Champasak Province, Lao PDR: A Case-Control Study.

Gallalee, S; Dantzer, E; Rerolle, F; Chindavongsa, K; Phongluxa, K; Lasichanh, W; Smith, JL; GOSLING, R; Lover, A; Hongvanthong, B; Bennett, A;

2024

International journal of environmental research and public health, (2024).21 12 10.3390/ijerph21121624.